The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

Abstract

Objectives. This review assesses the polypharmacy reduction potential of cinnamic acids (CAs) and some related compounds in managing three or more of the cluster of seven, pre- and post-type 2 diabetes mellitus (T2DM)-related features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation, and inflammation).

Keywords

• cinnamic acids and related compounds
• type 2 diabetes mellitus
• central obesity
• hyperglycemia
• hypertension
• dyslipidemia
• pro-thrombosis
• oxidation and inflammation